- Record: found
- Abstract: not found
- Article: not found
Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd) in front-line treatment of high-risk Multiple Myeloma: Results of the Safety Run-In cohort in the phase II, multicenter GMMG-CONCEPT trial—International Myeloma Workshop (IMW), 2019 Abstract. 2019, 25–26 [Abstract #OAB–023]
K Weisel, A.M. Asemissen, A Schieferdecker, B Besemer, M Zago, C. MANN, R Lutz, A Benner, D Tichy, C. BOKEMEYER
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.